PMID-31893927 – Bremelanotide New Drug Approved for Treating Hypoactive Sex

Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder.

Metadata

PMID: 31893927
Authors: Mayer D, Lynch SE
Journal: Ann Pharmacother
Year: 2020

Related Peptides

PT-141

Key Findings

Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder.

Tags

#research #narrative-review #sexual-health #evidence-level-V #pt-141-peptide